Hide Board Information

Show Board Information

NLS Pharmaceutics Ltd. NLSP

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/01/2022 9:41:12 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) Stock Message Board

1. NLSP Company Profile

    

2. NLSP Time & Sales

    

3. NLSP Recent News

    

4. NLSP Filings

    

5. NLSP Financials

    

6. NLSP Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

2	$NLSP 41% v17M c.74 f29,34M H.9297 ML.4201 late	znewcar1	11/01/2022 9:41:12 PM
1	NLSP 21% v532K c.7295 f19,5M H.7295 ML.371	znewcar1	09/07/2022 8:36:54 PM

Recent Articles

• SprintRay Streamlines Digital Dentistry with New API Integration
• Hyundai Motor Group's Pleos: Transforming Mobility with Software
• HashKey Group and Bosera Launch Innovative Tokenised ETF
• Seoul Invites Global Innovators for the 3rd Smart City Prize
• Empowering Cybersecurity with Cryptsoft's Latest SDKs
• AEON Pay Integrates with Bitget, Revolutionizing Payments
• IASO Bio Secures Milestone Approval for Innovative Myeloma Therapy
• Tony Susino Joins Keystone Dental as New CEO and Board Member
• Exploring the Rapid Growth of In-flight Connectivity by 2034
• Significant Growth Forecast for Lithium-Ion Battery Separators
• eVTOL Market Growth Projections Point to $3.2 Billion by 2040
• Intchains Group Secures $1 Million in Direct Offering with Confidence
• Fangzhou Inc. Celebrated as a Leader in AI Healthcare Innovation
• Exploring Innovations at the Global Technology Trade Fair 2025
• DBV Technologies Boosts Funding for Peanut Allergy Treatment
• Innovative Solutions for Future-Ready Secure Endpoint Computing
• JelloX Biotech Enhances Cancer Diagnosis with Advanced Technology
• Gravity Unveils Global Launch of Mobile Deck-Building Game
• Explore the Next Level of Gaming with GIGABYTE B760 GEN5
• Innovative Kids Helmet by Xnito: Next-Level Protection
• CoreWeave Sets Initial Public Offering Price for Investors
• Prime Drink Group Finalizes Funding and Issues Corrective Update
• Shanton's Innovative Breakthrough in Refractory Gout Treatment
• Shanton Pharma's SAP-001 Shows Promising Results in Gout Study
• April Marks Safe Digging Month: Southwest Gas' Commitment to Safety
• Transforming Organ Transportation with Medi-Ops and STA
• Savoring the Flavor: QDOBA's National Burrito Day Celebration
• Rockefeller Foundation's $100 Million Commitment to Children’s Nutrition
• Understanding the Class Action Lawsuit Against Geron Corporation
• Strategic Real Estate Sale by Birtcher and Belay Group
• Rockefeller Foundation's Bold Investment for Children's Nutrition
• JAPEX Strengthens U.S. Market Position with Peoria Resources
• Intercont (Cayman) Limited's Exciting Public Offering Journey
• Trevor Milton Gains Pardon, Redefining Justice and Freedom
• Building Bridges: The Growing US-China People-to-People Bonds
• Proposed Bill Aims to Replace Controversial OPT Program
• Reed's Inc. Reports Significant Growth and Future Outlook
• Yukon Metals Boosts Private Placement to C$10 Million Offering
• Bar Louie Launches Chapter 11 to Restructure for Future Growth
• XTI Aerospace Plans New Share Offering to Fuel Innovation
• Investigation into Tungray Technologies Inc's Securities Claims
• Investors Explore Class Action for Dave Inc. Allegations
• The Risks of Installing Shingles on Flat Roofs Explained
• Fluence Energy Faces Legal Challenge: Investor Deadline Approaches
• Nutex Health to Deliver Earnings Insights Soon: What to Expect
• VitalHub Demonstrates Growth with Strong 2024 Financials
• Advocating for Older Americans and Essential Health Programs
• Opportunity for Investors in Geron Corporation Class Action
• Key West Military Families File Fraud Claims Against Balfour Beatty
• B2Gold's Goose Project: New Plans for Gold Production Success